Related Experiment Video
Updated: Jun 5, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus
Jun Wang1, Jade Xiaoyan Qiu, Cinque Soto
1Department of chemistry, University of Pennsylvania, 231 south, 34th st, Philadelphia, PA 19104, USA.
Abstract:
The M2 proton channel from influenza A virus, a prototype for a class of viral ion channels known as viroporins, conducts protons along a chain of water molecules and ionizable sidechains, including His37. Recent studies highlight a delicate interplay between protein folding, proton binding, and proton conduction through the channel. Drugs inhibit proton conduction by binding to an aqueous cavity adjacent to M2's proton-selective filter, thereby blocking access of proton to the filter, and altering the energetic landscape of the channel and the energetics of proton-binding to His37.
Insights
Influenza M2 proton channel drugs block proton flow by binding near the filter. This binding alters the channel
Area of Science:
- Virology
- Biophysics
- Structural Biology
Background:
- Influenza A virus M2 protein forms proton-selective channels (viroporins).
- Proton conduction involves water molecules and ionizable residues like His37.
- Protein folding, proton binding, and conduction are intricately linked.
Purpose of the Study:
- To investigate the mechanism of M2 channel inhibition by drugs.
- To understand how drug binding affects proton conduction and His37 energetics.
Main Methods:
- Utilized biophysical techniques to study M2 channel function.
- Analyzed drug binding sites and their impact on proton pathways.
Main Results:
- Drugs bind to an aqueous cavity near the M2 proton filter.
- This binding obstructs proton access to the filter.
- Drug binding modifies the channel's energy landscape and His37 protonation energetics.
Conclusions:
- Drug binding at the M2 channel cavity is a viable inhibition strategy.
- Understanding these interactions aids in developing antiviral therapies.
- The study elucidates the complex interplay of M2 channel dynamics.
Related Concept Videos
Inhibitors Of Virion Release
Leaky Scanning
Influenza
Inhibitors of Viral Protein Synthesis
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...

